GB2415379A - Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of fungal infections and cancer - Google Patents

Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of fungal infections and cancer Download PDF

Info

Publication number
GB2415379A
GB2415379A GB0522200A GB0522200A GB2415379A GB 2415379 A GB2415379 A GB 2415379A GB 0522200 A GB0522200 A GB 0522200A GB 0522200 A GB0522200 A GB 0522200A GB 2415379 A GB2415379 A GB 2415379A
Authority
GB
United Kingdom
Prior art keywords
lichen
methyl
cirrhatum
fungal infections
orcinolcarboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0522200A
Other versions
GB2415379B (en
GB0522200D0 (en
Inventor
Suman Preet Singh Khanuja
Ranganathan Tiruppadiripuliyur
Vivek Kumar Gupta
Preeti Chand
Ankur Garg
Santosh Kumar Srivastava
Subash Chandra Verma
Dharmendra Saikia
Mahendra Pandurang Darokar
Ajit Kumar Shasany
Anirban Pal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Priority to GB0701454A priority Critical patent/GB2432530A/en
Priority to GB0716892A priority patent/GB2438552B/en
Publication of GB0522200D0 publication Critical patent/GB0522200D0/en
Publication of GB2415379A publication Critical patent/GB2415379A/en
Application granted granted Critical
Publication of GB2415379B publication Critical patent/GB2415379B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09Lichens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to the new use of an already known biomolecule methyl- b -orcinol carboxylate of formula (I) isolated from a lichen (Everniastrum cirrhatum), for treating pathogenic fungal infections of humans that are resistant to polyene and azole antibiotics such as amphotericin B, nystatin, clotrimazole etc.

Description

GB 2415379 A continuation (72) cont Santosh Srivastava Subash Chandra
Verma Dharmendra Saikia Mahendra Pandurang Darokar Alit Kumar Shasany Anirban Pal (74) Agent and/or Address for Service: Abel & Imray Red Lion Street, LONDON, WC1R 4PQ United Kingdom
GB0522200A 2003-03-31 2003-03-31 Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer Expired - Fee Related GB2415379B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0701454A GB2432530A (en) 2003-03-31 2003-03-31 Methyl-beta-orcinol carboxylate for use in treating fungal infections and antifungal compositions comprising it
GB0716892A GB2438552B (en) 2003-03-31 2003-03-31 Ethanolic extracts from lichen (Everniastrum Cirrhatum) for use for the treatment of fungal infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000097 WO2004087128A1 (en) 2003-03-31 2003-03-31 Methyl-β-orcinolcarboxylate from lichen (everniastrum cirrhatum) for use for the treatment of fungal infections and cancer

Publications (3)

Publication Number Publication Date
GB0522200D0 GB0522200D0 (en) 2005-12-07
GB2415379A true GB2415379A (en) 2005-12-28
GB2415379B GB2415379B (en) 2007-10-31

Family

ID=33104946

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0522200A Expired - Fee Related GB2415379B (en) 2003-03-31 2003-03-31 Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer

Country Status (6)

Country Link
JP (1) JP4498930B2 (en)
AU (1) AU2003226628A1 (en)
CA (1) CA2521055A1 (en)
DE (1) DE10394214T5 (en)
GB (1) GB2415379B (en)
WO (1) WO2004087128A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006137172A1 (en) * 2005-06-24 2006-12-28 Taiyo Kagaku Co., Ltd. Pest control agent of fungi or parasites for fish
JP2010202562A (en) * 2009-03-03 2010-09-16 Ogawa & Co Ltd Phenol-based antimicrobial agent
CN115989072A (en) * 2020-07-27 2023-04-18 兽医医药动力学有限责任公司 Lichen extract-based formulation for cervidae animals

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271064A (en) * 1991-11-27 1993-10-19 Dainippon Jochugiku Co Ltd Antibacterial agent for methicillin-resistant staphylococcus aureus and infection preventing method using the agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271064A (en) * 1991-11-27 1993-10-19 Dainippon Jochugiku Co Ltd Antibacterial agent for methicillin-resistant staphylococcus aureus and infection preventing method using the agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Journal of Medicinal and Aromatic Plant Sciences Vol. 22-23, No. 4A-1A, 2000, pages 169-172 *
Journal of Natural Products Vol. 48, No. 1, 1985, pages 157-158 *
Journal of Natural Products Vol. 49, No. 6, 1986, pages 1159-1160 *

Also Published As

Publication number Publication date
JP2006514969A (en) 2006-05-18
CA2521055A1 (en) 2004-10-14
GB2415379B (en) 2007-10-31
DE10394214T5 (en) 2006-03-16
WO2004087128A1 (en) 2004-10-14
JP4498930B2 (en) 2010-07-07
AU2003226628A1 (en) 2004-10-25
GB0522200D0 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
TNSN06071A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
CA2460939A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
TW200503708A (en) Gyrase inhibitors and uses thereof
MXPA03011197A (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents.
MY129319A (en) Crystal forms of azithromycin
AU2002358390A1 (en) Novel compounds
CY1105137T1 (en) DERIVATIVES OF AMINOCYCLOHEXYL ETHERS AND THEIR USES
MX2009004767A (en) Liquid preparation comprising a complex of pimobendan and cyclodextrin.
RS20050946A (en) Pyrrolodihydroisoquinolines as pde10 inhibitors
WO2006111681A3 (en) Arrangement for sterilising objects by electron bombardment
MXPA03011546A (en) New use.
WO2001036685A3 (en) Differential gene expression in cancer
CA2461567A1 (en) Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
AUPP589598A0 (en) Novel peptides
WO2005009951A3 (en) Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
TWI256304B (en) Pharmaceutical compositions based on azetidine derivatives
GB2415379A (en) Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of fungal infections and cancer
Lei et al. Riboflavin targets the cellular metabolic and ribosomal pathways of Candida albicans in vitro and exhibits efficacy against oropharyngeal candidiasis
NO20033318D0 (en) 2H-1-benzopyran derivatives, process of manufacture, and pharmaceutical compositions thereof
DE60220179D1 (en) SUBSTITUTED BENZOPYRANEES AS SELECTIVE AGONISTS ON THE ESTROGEN RECEPTOR BETA
DE60209359D1 (en) LÖSUNGSMITTELVERKLEBUNGSVERFAHREN
AU2002326509A1 (en) Dominant negative variants of methionine aminopeptidase 2 (metap2) and clinical uses thereof
WO2003086271A3 (en) Azole derivatives as antifungal agents
GEP20074089B (en) Triazole compounds useful in therapy
TW200741815A (en) Substrate processing method

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120331